Two common iron compounds increase the formation of a known biomarker for cancer, according to a new study of cancer cells from Chalmers University of Technology, Sweden.
Titanium is used in strong light - weight alloys (most notably with iron and aluminium) and its most commoncompound, titanium dioxide, is used in white pigments.